Navigation

Psychosis and schizophrenia in children and young people

Psychosis and schizophrenia: recognition and management of psychosis and schizophrenia in children and young people

Status: History
Publication date: January 2013
Wave: 24
Process: CG
Topic area:
 

NICE project team

Centre for clinical practice lead: Sarah Willett
Communications manager: Alice Law
Guidelines commissioning manager: Caroline Keir
Guidelines coordinator: Margaret Ghlaimi
Patient involvement lead: Erin Whittingham
Implementation lead: Alexa Biesty
Guidelines Development Group: The Guideline Development Group (GDG) oversees the development process.
Top


Email enquiries

If you have any queries please email nice@nice.org.uk
Top


 

Provisional schedule

Scoping workshop: 16 November 2010
Consultation on draft scope with stakeholders: TBC
Consultation on draft guideline with stakeholders: TBC
Publication date: January 2013
Top


 

Project history

Date Update

9 August 2012

 

The draft guideline is out for consultation with stakeholders. If you wish to comment, you need to do so via one of the registered stakeholder organisations listed, by the deadline shown.
20 July 2012 The consultation for this guideline has been delayed. Stakeholders will be informed of the new consultation date in due course.
17 May 2011 Development of the clinical guideline is under way and is being led by the National Collaborating Centre. The Guideline Development Group meets regularly to oversee and assist the identification, review and synthesis of the evidence, the incorporation of expert consensus opinion and the translation of the evidence into recommendations for practice and audit criteria. Two versions of the guideline are under preparation: a full guideline and a NICE short-form guideline.  Please see timescales above for dates of consultation with stakeholders.
17 May 2011 The NCCs may make a focussed call for evidence on specific clinical questions or subquestions, after it has done initial searches. It will be able to make a call at any point during development of the guideline, and stakeholders will usually be given 4 weeks to respond. The NCC will approach all registered stakeholders for this evidence. The NCC may not issue any calls for evidence for a guideline if the Guideline Development Group (GDG) feels it is not necessary. In addition, the NCCs will accept relevant confidential data for consideration by the GDG.
17 May 2011 The scope defines what aspects of care are covered by the guideline and to whom it applies. Comments that were made by stakeholders during the consultation on the scope can be seen in the scope consultation table. The Guideline Development Group (GDG) oversees the development process.
Top


 

Key documents

This page was last updated: 22 January 2013

Accessibility | Cymraeg | Freedom of information | Vision Impaired | Contact Us | Glossary | Data protection | Copyright | Disclaimer | Terms and conditions

Copyright 2014 National Institute for Health and Care Excellence. All rights reserved.

Selected, reliable information for health and social care in one place

Accessibility | Cymraeg | Freedom of information | Vision Impaired | Contact Us | Glossary | Data protection | Copyright | Disclaimer | Terms and conditions

Copyright 2014 National Institute for Health and Care Excellence. All rights reserved.

Accessibility | Cymraeg | Freedom of information | Vision Impaired | Contact Us | Glossary | Data protection | Copyright | Disclaimer | Terms and conditions

Copyright 2014 National Institute for Health and Care Excellence. All rights reserved.